TG THERAPEUTICS, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
TG THERAPEUTICS, INC. (TGTX) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$722.00 thousand for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2019-11-12
- TG THERAPEUTICS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2019-09-30 was -$44.00K.
- TG THERAPEUTICS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2019-06-30 was $457.00K, a 91.82% decline year-over-year.
- TG THERAPEUTICS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2019-03-31 was -$1.14M, a 163.34% decline year-over-year.
- TG THERAPEUTICS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2018-12-31 was $238.00K.
- TG THERAPEUTICS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2018 was $1.18M.
- TG THERAPEUTICS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was -$8.21M, a 130.92% decline from fiscal 2016.
- TG THERAPEUTICS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was $26.55M.
- TG THERAPEUTICS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$24.69M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 25 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 28 month |
|---|---|---|---|---|---|---|---|---|---|
| 2019-09-30 | -$44.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $413.00K derived: sum of 2 quarters · filed 2019-11-12 | -$722.00K 10-Q · filed 2019-11-12 | -$484.00K derived: sum of 4 quarters · filed 2019-11-12 | |||||
| 2019-06-30 | $457.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$678.00K 10-Q · filed 2019-08-09 | -$440.00K derived: sum of 3 quarters · filed 2019-08-09 | -$6.88M derived: sum of 4 quarters · filed 2019-11-12 | |||||
| 2019-03-31 | -$1.14M 10-Q · filed 2019-05-10 | -$897.00K derived: sum of 2 quarters · filed 2019-05-10 | -$7.33M derived: sum of 3 quarters · filed 2019-11-12 | -$1.75M derived: sum of 4 quarters · filed 2019-11-12 | |||||
| 2018-12-31 | $238.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$6.20M derived: sum of 2 quarters · filed 2019-11-12 | -$612.00K derived: sum of 3 quarters · filed 2019-11-12 | $1.18M 10-K · filed 2019-03-01 | |||||
| 2018-09-30 | -$6.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$850.00K derived: sum of 2 quarters · filed 2019-11-12 | $942.00K 10-Q · filed 2019-11-12 | -$27.06M derived: sum of 4 quarters · filed 2019-11-12 | |||||
| 2018-06-30 | $5.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $7.38M 10-Q · filed 2019-08-09 | -$20.63M derived: sum of 3 quarters · filed 2019-08-09 | -$11.83M derived: sum of 4 quarters · filed 2019-08-09 | |||||
| 2018-03-31 | $1.79M 10-Q · filed 2019-05-10 | -$26.21M derived: sum of 2 quarters · filed 2019-05-10 | -$17.41M derived: sum of 3 quarters · filed 2019-05-10 | -$12.42M derived: sum of 4 quarters · filed 2019-05-10 | |||||
| 2017-12-31 | -$28.01M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$19.21M derived: sum of 2 quarters · filed 2019-03-01 | -$14.21M derived: sum of 3 quarters · filed 2019-03-01 | -$8.21M 10-K · filed 2019-03-01 | -$8.21M 10-K · filed 2018-03-15 | ||||
| 2017-09-30 | $8.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $13.80M derived: sum of 2 quarters · filed 2018-11-09 | $19.80M 10-Q · filed 2018-11-09 | $19.80M 10-Q · filed 2017-11-09 | $31.28M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2017-06-30 | $5.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $11.00M 10-Q · filed 2018-08-09 | $11.00M 10-Q · filed 2017-08-09 | $22.48M derived: sum of 3 quarters · filed 2019-03-01 | $38.05M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2017-03-31 | $6.00M 10-Q · filed 2018-05-10 | $17.48M derived: sum of 2 quarters · filed 2019-03-01 | $33.05M derived: sum of 3 quarters · filed 2019-03-01 | $34.47M derived: sum of 4 quarters · filed 2019-03-01 | |||||
| 2016-12-31 | $11.48M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $27.05M derived: sum of 2 quarters · filed 2019-03-01 | $28.47M derived: sum of 3 quarters · filed 2019-03-01 | $26.55M 10-K · filed 2019-03-01 | $26.55M 10-K · filed 2017-03-16 | ||||
| 2016-09-30 | $15.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $16.99M derived: sum of 2 quarters · filed 2017-11-09 | $15.07M 10-Q · filed 2017-11-09 | $17.54M derived: sum of 4 quarters · filed 2018-03-15 | |||||
| 2016-06-30 | $1.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$509.98K 10-Q · filed 2017-08-09 | $1.97M derived: sum of 3 quarters · filed 2018-03-15 | $2.05M derived: sum of 4 quarters · filed 2018-03-15 | |||||
| 2016-03-31 | -$1.92M 10-Q · filed 2017-05-10 | $554.93K derived: sum of 2 quarters · filed 2018-03-15 | $631.50K derived: sum of 3 quarters · filed 2018-03-15 | -$30.45M derived: sum of 4 quarters · filed 2018-03-15 | |||||
| 2015-12-31 | $2.48M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $2.56M derived: sum of 2 quarters · filed 2018-03-15 | -$28.53M derived: sum of 3 quarters · filed 2018-03-15 | -$24.69M 10-K · filed 2018-03-15 | |||||
| 2015-09-30 | $76.57K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$31.01M derived: sum of 2 quarters · filed 2016-11-09 | -$27.16M 10-Q · filed 2016-11-09 | -$36.30M derived: sum of 4 quarters · filed 2017-03-16 | |||||
| 2015-06-30 | -$31.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$27.24M 10-Q · filed 2016-08-09 | -$36.37M derived: sum of 3 quarters · filed 2017-03-16 | -$36.38M derived: sum of 4 quarters · filed 2017-03-16 | |||||
| 2015-03-31 | $3.84M 10-Q · filed 2016-05-10 | -$5.29M derived: sum of 2 quarters · filed 2017-03-16 | -$5.29M derived: sum of 3 quarters · filed 2017-03-16 | -$14.51M derived: sum of 4 quarters · filed 2017-03-16 | |||||
| 2014-12-31 | -$9.13M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | -$9.13M derived: sum of 2 quarters · filed 2017-03-16 | -$18.35M derived: sum of 3 quarters · filed 2017-03-16 | -$18.36M 10-K · filed 2017-03-16 | |||||
| 2014-09-30 | -$1.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$9.22M derived: sum of 2 quarters · filed 2015-11-09 | -$9.22M 10-Q · filed 2015-11-09 | -$14.14M derived: sum of 4 quarters · filed 2016-03-15 | |||||
| 2014-06-30 | -$9.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$9.22M 10-Q · filed 2015-08-10 | -$14.14M derived: sum of 3 quarters · filed 2016-03-15 | -$14.15M derived: sum of 4 quarters · filed 2016-03-15 | |||||
| 2014-03-31 | -$3.17K 10-Q · filed 2015-05-11 | -$4.93M derived: sum of 2 quarters · filed 2016-03-15 | -$4.93M derived: sum of 3 quarters · filed 2016-03-15 | -$4.93M derived: sum of 4 quarters · filed 2016-03-15 | -$4.92M 10-Q · filed 2014-05-14 | ||||
| 2013-12-31 | -$4.92M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | -$4.92M derived: sum of 2 quarters · filed 2016-03-15 | -$4.93M derived: sum of 3 quarters · filed 2016-03-15 | -$4.93M 10-K · filed 2016-03-15 | -$4.92M 10-K · filed 2014-03-07 | ||||
| 2013-09-30 | -$1.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | -$3.30K derived: sum of 2 quarters · filed 2014-11-14 | -$3.30K 10-Q · filed 2014-11-14 | ||||||
| 2013-06-30 | -$1.67K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-24 | -$1.67K 10-Q · filed 2014-07-24 | |||||||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-14 | ||||||||
| 2012-12-31 | -$1.40K 10-K · filed 2014-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |